1 |
(4s)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile |
- |
- |
- |
- |
231 1件: 231 💬 |
2 |
(r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide |
Pyrazole |
- |
- |
- |
058 1件: 58 💬 |
3 |
(s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium |
- |
- |
- |
- |
086 1件: 86 💬 |
4 |
1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride |
Piperazine |
6件: D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 1件: 58 💬 |
5 |
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid |
- |
- |
- |
- |
299 1件: 299 💬 |
6 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
7 |
1500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
8 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 1件: 6 💬 |
9 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 1件: 6 💬 |
10 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 1件: 6 💬 |
11 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 1件: 6 💬 |
12 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
13 |
2% chlorhexidine solution wipes |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
14 |
2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat |
- |
- |
- |
- |
028 1件: 28 💬 |
15 |
2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate |
- |
- |
- |
- |
028 1件: 28 💬 |
16 |
2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride |
- |
- |
- |
- |
006 2件: 6 , 162 💬 |
17 |
250mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
18 |
3 mg [14c]-a4250 capsule |
- |
- |
- |
- |
093 2件: 93, 297 💬 |
19 |
4% chlorhexidine gluconate liquid skin cleanser |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
20 |
4-{[(1r,2s,3s,5s,7s)-5-hydroxy-2-adamantyl]amino}-1h-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide |
- |
- |
- |
- |
046 1件: 46 💬 |
21 |
500mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
22 |
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid |
- |
- |
- |
- |
097 1件: 97 💬 |
23 |
750mg mesalazine pellets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
24 |
95% pure ecgc capsules 200mg |
- |
- |
- |
- |
013 1件: 13 💬 |
25 |
[18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane |
- |
- |
- |
- |
006 1件: 6 💬 |
26 |
Aav9-cag-coh-sgsh |
- |
- |
- |
- |
019 1件: 19 💬 |
27 |
Acalabrutinib |
Acalabrutinib |
1件: D10893 D10893 💬 |
BTK 1件: BTK 💬 |
B cell receptor signaling pathway 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 2件: 46, 61 💬 |
28 |
Acamprosate |
Acamprosate |
2件: D02780 D02780, D07058 D07058 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 2件: 6 , 206 💬 |
29 |
Accordion pill carbidopa/levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
30 |
Accordion pill ¿ carbidopa/levodopa 50/400 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
31 |
Accordion pill ¿ carbidopa/levodopa 50/500 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
32 |
Accordion pill? carbidopa/levodopa 50/400 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
33 |
Accordion pill? carbidopa/levodopa 50/500 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
34 |
Accordion pill™ carbidopa/levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
35 |
Accordion pill™ carbidopa/levodopa 50/400 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
36 |
Accordion pill™ carbidopa/levodopa 50/500 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
37 |
Acetyl- l- carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
265 1件: 265 💬 |
38 |
Acetyl-l-carnitine |
Acetylcarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 1件: 298 💬 |
39 |
Acetyl-l-carnitine 1000mg 2x per day for 3 months |
Acetylcarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 1件: 298 💬 |
40 |
Acz885 150 mg (canakinumab) |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
107 1件: 107 💬 |
41 |
Advagraf prolonged-release hard capsules |
- |
- |
- |
- |
299 1件: 299 💬 |
42 |
Ag011 - capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
43 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
44 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
046 1件: 46 💬 |
45 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
046 1件: 46 💬 |
46 |
Alemtuzumab (campath ) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
060 1件: 60 💬 |
47 |
Alemtuzumab (campath) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
015 1件: 15 💬 |
48 |
Alemtuzumab (gz402673) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
49 |
Alemtuzumab 0.2 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 2件: 65, 164 💬 |
50 |
Alemtuzumab 0.3 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 2件: 65, 164 💬 |
51 |
Alemtuzumab 12 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
52 |
Alemtuzumab 24 mg |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
53 |
Alemtuzumab and rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
060 1件: 60 💬 |
54 |
Alemtuzumab gz402673 |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
55 |
Alemtuzumab immunotherapy |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
56 |
Alemtuzumab injection |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
57 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 1件: 13 💬 |
58 |
Alemtuzumab, rituximab |
Alemtuzumab |
2件: D02802 D02802, D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
063 1件: 63 💬 |
59 |
Alentuzumab (campath) |
- |
- |
- |
- |
065 1件: 65 💬 |
60 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
61 |
Allogeneic cardiosphere-derived cells (cap-1002) |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
62 |
Allogeneic human cardiosphere-derived stem cells |
- |
- |
- |
- |
086 1件: 86 💬 |
63 |
Alpha-lipoic acid and l-acetyl carnitine |
Levocarnitine |
5件: D00048 D00048, D00086 D00086, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 1件: 5 💬 |
64 |
Alprostadil |
Alprostadil |
2件: D00180 D00180, D02705 D02705 💬 |
PTGER1 1件: PTGER1 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 2件: 51, 70 💬 |
65 |
Amantadine hcl extended release capsule |
Amantadine |
2件: D00777 D00777, D07441 D07441 💬 |
GRIN1 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 1件: 6 💬 |
66 |
Ambrisentan plus spironolactone |
Ambrisentan |
2件: D00443 D00443, D07077 D07077 💬 |
EDNRA 2件: EDNRA, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 8件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
67 |
Amorphous calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
235 1件: 235 💬 |
68 |
Anhydrous carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
69 |
Anti-(human tumor necrosis factor) immunoglobulin g (human-mouse monoclonal ca2 heavy chain) |
- |
- |
- |
- |
271 1件: 271 💬 |
70 |
Anti-cd19-car-t cells |
- |
- |
- |
- |
049 1件: 49 💬 |
71 |
Anti-von willebrand factor nanobody, caplacizumab |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
72 |
Anti-von willebrand factor nanobody, inn = caplacizumab |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
73 |
Antigen-specific t cells cart/ctl and dcvac |
- |
- |
- |
- |
034 1件: 34 💬 |
74 |
Antimicrobial therapy: co-trimoxazole or doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
085 1件: 85 💬 |
75 |
Antioxidant plus pregabalin |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
298 1件: 298 💬 |
76 |
Apriso 0.375g er cap |
- |
- |
- |
- |
097 1件: 97 💬 |
77 |
Apriso 375 mg extended-release capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
78 |
Arimoclomol (hard gelatine capsule) |
Arimoclomol |
3件: D00115 D00115, D06892 D06892, D11374 D11374 💬 |
- |
- |
019 1件: 19 💬 |
79 |
Arimoclomol (hpmc capsule) |
Arimoclomol |
1件: D11374 D11374 💬 |
- |
- |
019 1件: 19 💬 |
80 |
Ascal(r) / carbasalate calcium |
Calcium |
1件: D03385 D03385 💬 |
- |
- |
046 1件: 46 💬 |
81 |
Asp015k hydrobromide, as1940150-br, jkt-201a, 4-{[(1r,2s,3s,5s,7s)-5-hydroxy-2-adamantyl]amino}-1h-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide |
- |
- |
- |
- |
046 1件: 46 💬 |
82 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
1件: D00109 D00109 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
83 |
At2221 65 mg formulated capsules |
- |
- |
- |
- |
256 1件: 256 💬 |
84 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
85 |
Atorvastatin 10mg |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 1件: 63 💬 |
86 |
Atorvastatin 20mg |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 1件: 63 💬 |
87 |
Atorvastatin calcium |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
265 1件: 265 💬 |
88 |
Atorvastatin tablet 20 mg |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 1件: 46 💬 |
89 |
Avcn583601 (3% cannabidiol cream) |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
036 1件: 36 💬 |
90 |
Azathioprine (aza) caps |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
91 |
Azathioprine in case of endoscopic recurrence |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
92 |
Azathioprine or mesalazine |
Azathioprine |
3件: D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
93 |
Azithromycin 250mg capsule |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
084 1件: 84 💬 |
94 |
Aztreonam |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
228 2件: 228, 299 💬 |
95 |
Aztreonam for inhalation (ai) |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
96 |
Aztreonam for inhalation solution |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
97 |
Aztreonam for inhalation solution (azli) |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
98 |
Aztreonam lysine |
Aztreonam |
3件: D00240 D00240, D02304 D02304, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
99 |
Aztreonam lysine for inhalation |
Aztreonam |
3件: D00240 D00240, D02304 D02304, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
100 |
Aztreonam lysine for inhalation (azli) |
Aztreonam |
3件: D00240 D00240, D02304 D02304, D06558 D06558 💬 |
- |
- |
228 1件: 228 💬 |
101 |
Aztreonam solución para inhalación |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
102 |
Bacille calmette-guerin vaccine |
- |
- |
- |
- |
013 1件: 13 💬 |
103 |
Bacille of calmette-guerin |
- |
- |
- |
- |
013 1件: 13 💬 |
104 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
105 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
106 |
Baclofen er capsules (grs) 30mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
107 |
Baclofen er capsules (grs) 40mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
108 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
1件: D00241 D00241 💬 |
GABBR1 2件: GABBR1, GABBR2 💬 |
Estrogen signaling pathway 7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
109 |
Bardoxolone methyl capsules |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
066 4件: 66, 67, 86, 222 💬 |
110 |
Bardoxolone methyl oral capsule |
Bardoxolone |
2件: D09584 D09584, D09585 D09585 💬 |
- |
- |
067 1件: 67 💬 |
111 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
112 |
Behavioral: building better caregivers workshop |
- |
- |
- |
- |
006 1件: 6 💬 |
113 |
Behavioral: cannabis questionnaire |
Medical Cannabis |
- |
- |
- |
046 2件: 46, 271 💬 |
114 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 1件: 13 💬 |
115 |
Behavioral: protein and calorie controlled diet |
- |
- |
- |
- |
251 1件: 251 💬 |
116 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
117 |
Best supportive care (bsc) |
- |
- |
- |
- |
331 1件: 331 💬 |
118 |
Beta carotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
119 |
Beta carotene from dunaliella algae |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
120 |
Beta-carotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
013 1件: 13 💬 |
121 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
097 1件: 97 💬 |
122 |
Bis-choline tetrathiomolybdate |
Choline |
1件: D07690 D07690 💬 |
- |
- |
171 1件: 171 💬 |
123 |
Bitter candytuft fresh plant extract |
- |
- |
- |
- |
097 1件: 97 💬 |
124 |
Bms-986165 capsule |
- |
- |
- |
- |
049 1件: 49 💬 |
125 |
Boswellia serrata extract ps0201bo capsules |
Indian frankincense |
- |
- |
- |
013 1件: 13 💬 |
126 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
127 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 1件: 97 💬 |
128 |
Break in l-carnitine treatment |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
316 1件: 316 💬 |
129 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 1件: 96 💬 |
130 |
Budesonide ( zentacort capsules 3mg ) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
131 |
Budesonide 6 mg capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
132 |
Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
133 |
Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
134 |
Budesonide 9 mg capsules, hard (bux-pv) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
135 |
Budesonide 9 mg capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
136 |
Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
137 |
Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
138 |
C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
276 1件: 276 💬 |
139 |
Ca |
- |
- |
- |
- |
234 1件: 234 💬 |
140 |
Ca2 |
- |
- |
- |
- |
271 1件: 271 💬 |
141 |
Cabaletta |
Trehalose |
- |
- |
- |
018 2件: 18, 113 💬 |
142 |
Cabaletta for iv infusion once weekly during 24 weeks |
Trehalose |
- |
- |
- |
018 1件: 18 💬 |
143 |
Cabaser |
- |
- |
- |
- |
006 1件: 6 💬 |
144 |
Cabaseril |
- |
- |
- |
- |
006 1件: 6 💬 |
145 |
Cabaseril, 1,0 mg tablette |
- |
- |
- |
- |
006 1件: 6 💬 |
146 |
Cabaseril, 2,0 mg tablette |
- |
- |
- |
- |
006 1件: 6 💬 |
147 |
Cabergolina |
Cabergoline |
1件: D00987 D00987 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
148 |
Cabergoline |
Cabergoline |
1件: D00987 D00987 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 3件: 6 , 74, 75 💬 |
149 |
Cabergoline teva |
Cabergoline |
1件: D00987 D00987 💬 |
DRD2 2件: DRD2, PRL 💬 |
Alcoholism 12件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 1件: 75 💬 |
150 |
Cablivi |
- |
- |
- |
- |
064 1件: 64 💬 |
151 |
Cabozantinib |
Cabozantinib |
1件: D10062 D10062 💬 |
AXL 3件: AXL, KDR, MET 💬 |
Adherens junction 24件: Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway |
034 1件: 34 💬 |
152 |
Cael-101 |
- |
- |
- |
- |
028 1件: 28 💬 |
153 |
Caffeic acid tablets |
- |
- |
- |
- |
063 1件: 63 💬 |
154 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
155 |
Caffeine 100 mg |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
156 |
Caffeine 100-200 mg bid |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
157 |
Caffeine alkaloid |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
158 |
Calcichew d3 forte |
- |
- |
- |
- |
113 1件: 113 💬 |
159 |
Calcichew tablets |
- |
- |
- |
- |
274 1件: 274 💬 |
160 |
Calcifediol |
Calcifediol |
1件: D00122 D00122 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
113 1件: 113 💬 |
161 |
Calcineurin inhibitors |
- |
- |
- |
- |
050 1件: 50 💬 |
162 |
Calcineurin inhibitors maintenance |
- |
- |
- |
- |
067 1件: 67 💬 |
163 |
Calcio |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
164 |
Calcio folinato dc.it |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
165 |
Calcipotriene |
Calcipotriol |
1件: D01125 D01125 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 1件: 51 💬 |
166 |
Calcipotriol |
Calcipotriol |
1件: D01125 D01125 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
036 1件: 36 💬 |
167 |
Calcitonin |
- |
- |
- |
- |
225 1件: 225 💬 |
168 |
Calcitonin (salmon) |
Salmon, unspecified |
- |
- |
- |
225 1件: 225 💬 |
169 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 2件: 96, 97 💬 |
170 |
Calcitriol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
171 |
Calcitriol & calcium |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
172 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
173 |
Calcium and cholecalciferol |
Calcium |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 1件: 46 💬 |
174 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
175 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
176 |
Calcium carbonate and alphacalcidol |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
235 1件: 235 💬 |
177 |
Calcium carbonate d |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
053 1件: 53 💬 |
178 |
Calcium channel blockers |
Calcium |
- |
- |
- |
051 1件: 51 💬 |
179 |
Calcium citrate |
Calcium |
1件: D00933 D00933 💬 |
- |
- |
046 3件: 46, 84, 235 💬 |
180 |
Calcium citrate with vitamin d2 |
Calcium |
2件: D00187 D00187, D00933 D00933 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
084 1件: 84 💬 |
181 |
Calcium gluconate |
Calcium |
1件: D00935 D00935 💬 |
- |
- |
214 3件: 214, 215, 235 💬 |
182 |
Calcium lactate |
Calcium |
2件: D00936 D00936, D02254 D02254 💬 |
- |
- |
235 1件: 235 💬 |
183 |
Calcium levofolinate |
Calcium |
- |
- |
- |
013 1件: 13 💬 |
184 |
Calcium rosuvastatin |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 1件: 79 💬 |
185 |
Calcium, dietary |
Calcium |
- |
- |
- |
298 1件: 298 💬 |
186 |
Cald hr-d (high-risk, regimen c) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
187 |
Cald hr-d (high-risk, regimen d) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
188 |
Cald sr-a (standard-risk, regimen a) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
189 |
Cald sr-b (standard-risk, regimen b) |
- |
- |
- |
- |
019 5件: 19, 20, 125, 234, 326 💬 |
190 |
Calfactant |
Calfactant |
1件: D03317 D03317 💬 |
- |
- |
299 1件: 299 💬 |
191 |
Calogen |
- |
- |
- |
- |
002 1件: 2 💬 |
192 |
Caltrate pill |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
193 |
Calvan® 100 mg |
- |
- |
- |
- |
008 1件: 8 💬 |
194 |
Caly-002 |
- |
- |
- |
- |
098 1件: 98 💬 |
195 |
Cam-3001 |
Mavrilimumab |
1件: D09930 D09930 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
046 1件: 46 💬 |
196 |
Cam2043 |
- |
- |
- |
- |
051 1件: 51 💬 |
197 |
Campath |
- |
- |
- |
- |
019 12件: 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
198 |
Campath -1h |
- |
- |
- |
- |
065 1件: 65 💬 |
199 |
Campath 1h |
- |
- |
- |
- |
060 4件: 60, 65, 164, 285 💬 |
200 |
Campath, busulfan, clofarabine |
Busulfan |
2件: D00248 D00248, D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
326 1件: 326 💬 |
201 |
Campath, chemo and/or tbi allo sct |
- |
- |
- |
- |
060 3件: 60, 62, 283 💬 |
202 |
Campath, fludarabine, cyclophosphamide |
Cyclophosphamide |
4件: D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 2件: 65, 284 💬 |
203 |
Campath-1h |
- |
- |
- |
- |
019 6件: 19, 20, 60, 234, 285, 326 💬 |
204 |
Campath-1h (alemtuzumab) |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
060 1件: 60 💬 |
205 |
Canakinumab |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 10件: 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
206 |
Canakinumab (acz885) |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 1件: 106 💬 |
207 |
Canakinumab (company code: acz885d) |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 1件: 106 💬 |
208 |
Canakinumab (investigational) |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 1件: 46 💬 |
209 |
Canakinumab (proposed) |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 1件: 46 💬 |
210 |
Canakinumab (who approval pending) |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 1件: 106 💬 |
211 |
Canakinumab injection [ilaris] |
Canakinumab |
1件: D09315 D09315 💬 |
IL1B 1件: IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications 42件: AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
113 1件: 113 💬 |
212 |
Candesartan |
Candesartan |
1件: D00522 D00522 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 2件: 58, 67 💬 |
213 |
Candesartan and cilnidipine |
Candesartan |
2件: D00522 D00522, D01173 D01173 💬 |
AGTR1 6件: AGTR1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
AGE-RAGE signaling pathway in diabetic complications 48件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 1件: 67 💬 |
214 |
Candesartan plus non-ccb agents |
Candesartan |
1件: D00522 D00522 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
067 1件: 67 💬 |
215 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
216 |
Cannabidiol (cbd) |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 6件: 6 , 140, 144, 145, 156, 158 💬 |
217 |
Cannabidiol , synthetic form |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
096 1件: 96 💬 |
218 |
Cannabidiol / dronabinol capsule 5 mg+2,5 mg |
Cannabidiol |
2件: D00306 D00306, D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
219 |
Cannabidiol botanical drug substance (cbd bds) |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
220 |
Cannabidiol capsule 5 mg |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
221 |
Cannabidiol oral solution |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
140 4件: 140, 144, 145, 193 💬 |
222 |
Cannabidiol tablet 10 mg |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
046 2件: 46, 271 💬 |
223 |
Cannabidiol vaginal suppository |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
226 1件: 226 💬 |
224 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
225 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
226 |
Cannabis oil |
Medical Cannabis |
- |
- |
- |
006 1件: 6 💬 |
227 |
Cannabis sativa extract oromucosal spray |
Medical Cannabis |
- |
- |
- |
002 1件: 2 💬 |
228 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97 💬 |
229 |
Cannador |
- |
- |
- |
- |
013 1件: 13 💬 |
230 |
Cap-1002 |
CAP-1002 |
- |
- |
- |
113 1件: 113 💬 |
231 |
Capecitabine |
Capecitabine |
1件: D01223 D01223 💬 |
TYMS 1件: TYMS 💬 |
Antifolate resistance 4件: Antifolate resistance, Metabolic pathways, One carbon pool by folate, Pyrimidine metabolism |
094 1件: 94 💬 |
232 |
Capillarema |
- |
- |
- |
- |
051 1件: 51 💬 |
233 |
Caplacizumab |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
234 |
Caplacizumab (alx-0081) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
235 |
Caplacizumab (an anti-von willebrand factor nanobody alx-0081) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
236 |
Caplacizumab (an anti-von willebrand factor nanobody) |
Caplacizumab |
1件: D11160 D11160 💬 |
VWF 1件: VWF 💬 |
Complement and coagulation cascades 8件: Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 1件: 64 💬 |
237 |
Caprylic triglyceride |
Tricaprylin |
- |
- |
- |
013 1件: 13 💬 |
238 |
Capsaicin |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 5件: 2 , 6 , 19, 86, 226 💬 |
239 |
Capsaicin challenge |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 1件: 2 💬 |
240 |
Capsaicin vapor |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
006 1件: 6 💬 |
241 |
Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
242 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 1件: 13 💬 |
243 |
Captopril |
Captopril |
1件: D00251 D00251 💬 |
ACE 1件: ACE 💬 |
Chagas disease 6件: Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
017 2件: 17, 86 💬 |
244 |
Capture |
Bifenthrin |
- |
- |
- |
006 2件: 6 , 46 💬 |
245 |
Carbaglu |
- |
- |
- |
- |
245 2件: 245, 246 💬 |
246 |
Carbamazepine |
Carbamazepine |
1件: D00252 D00252 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 2件: 13, 231 💬 |
247 |
Carbasalate calcium |
Calcium |
1件: D03385 D03385 💬 |
- |
- |
046 1件: 46 💬 |
248 |
Carbetocin |
Carbetocin |
1件: D07229 D07229 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
249 |
Carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
250 |
Carbidopa (fu) |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
251 |
Carbidopa 20 mg |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
252 |
Carbidopa 200mg oral dose |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 2件: 6 , 17 💬 |
253 |
Carbidopa 27.5 mg |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
254 |
Carbidopa 65 mg capsule |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
255 |
Carbidopa and levodopa 25mg/100mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
256 |
Carbidopa and levodopa tablets, usp |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
257 |
Carbidopa anidra |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
258 |
Carbidopa fu |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
259 |
Carbidopa inn |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
260 |
Carbidopa levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
261 |
Carbidopa monohydrate |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
262 |
Carbidopa, levodopa, entacapone |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
263 |
Carbidopa- levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
264 |
Carbidopa-4'-monophosphate |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
265 |
Carbidopa-levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
002 3件: 2 , 4 , 6 💬 |
266 |
Carbidopa-levodopa 25 mg-100 mg oral tablet |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
267 |
Carbidopa/l-dopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
268 |
Carbidopa/l-dopa/entacapone |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
269 |
Carbidopa/levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
270 |
Carbidopa/levodopa, immediate release |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
271 |
Carbidopa/levodopa/entacapone |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
272 |
Carbidopamonohydraat |
- |
- |
- |
- |
006 1件: 6 💬 |
273 |
Carbodopa levadopa |
- |
- |
- |
- |
006 1件: 6 💬 |
274 |
Carbodopa/levadopa |
- |
- |
- |
- |
006 1件: 6 💬 |
275 |
Carbohydrates intake |
- |
- |
- |
- |
257 1件: 257 💬 |
276 |
Carbolithium |
- |
- |
- |
- |
002 1件: 2 💬 |
277 |
Carbolithium*100cps 150mg |
- |
- |
- |
- |
002 1件: 2 💬 |
278 |
Carbomer |
Carbomer |
- |
- |
- |
053 1件: 53 💬 |
279 |
Carbomer 974p |
Carbomer |
- |
- |
- |
053 1件: 53 💬 |
280 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
281 |
Carbon dioxide |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
050 3件: 50, 51, 97 💬 |
282 |
Carbon monoxide |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
085 3件: 85, 86, 298 💬 |
283 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
284 |
Carbonate de lithium |
Carbonate ion |
- |
- |
- |
002 1件: 2 💬 |
285 |
Carboplatin |
Carboplatin |
1件: D01363 D01363 💬 |
- |
- |
028 4件: 28, 34, 60, 85 💬 |
286 |
Carboxymethylcellulose |
Carboxymethylcellulose |
1件: D07622 D07622 💬 |
- |
- |
035 2件: 35, 162 💬 |
287 |
Cardicor |
- |
- |
- |
- |
113 1件: 113 💬 |
288 |
Cardicor (merck brand) |
- |
- |
- |
- |
113 1件: 113 💬 |
289 |
Cardiovascular profile |
- |
- |
- |
- |
113 1件: 113 💬 |
290 |
Cardura |
- |
- |
- |
- |
067 1件: 67 💬 |
291 |
Care as usual |
- |
- |
- |
- |
015 1件: 15 💬 |
292 |
Carfilzomib |
Carfilzomib |
1件: D08880 D08880 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 1件: 28 💬 |
293 |
Carglumic acid |
Carglumic acid |
1件: D07130 D07130 💬 |
CPS1 1件: CPS1 💬 |
Alanine, aspartate and glutamate metabolism 6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism |
245 3件: 245, 246, 251 💬 |
294 |
Carglumic acid (carbaglu®) |
Carglumic acid |
1件: D07130 D07130 💬 |
CPS1 1件: CPS1 💬 |
Alanine, aspartate and glutamate metabolism 6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism |
245 2件: 245, 246 💬 |
295 |
Carisbamate |
Carisbamate |
1件: D06573 D06573 💬 |
- |
- |
144 1件: 144 💬 |
296 |
Carmustine |
Carmustine |
1件: D00254 D00254 💬 |
- |
- |
011 5件: 11, 13, 14, 28, 60 💬 |
297 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
7件: D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A 2件: TOP2A, TOP2B 💬 |
Platinum drug resistance 1件: Platinum drug resistance |
013 1件: 13 💬 |
298 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
299 |
Carnosine |
Carnosine |
- |
- |
- |
006 2件: 6 , 13 💬 |
300 |
Carnosine supplementation |
Carnosine |
- |
- |
- |
006 1件: 6 💬 |
301 |
Carnosine, capsulle, 2 g/day, 8 weeks |
Carnosine |
- |
- |
- |
013 1件: 13 💬 |
302 |
Carrageenan |
- |
- |
- |
- |
097 1件: 97 💬 |
303 |
Carvedilol |
Carvedilol |
2件: D00255 D00255, D03415 D03415 💬 |
ADRA1A 5件: ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 5件: 6 , 57, 86, 113, 210 💬 |
304 |
Carvi extractum fluidum |
- |
- |
- |
- |
097 1件: 97 💬 |
305 |
Cas # in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 1件: 254 💬 |
306 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 1件: 58 💬 |
307 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 1件: 58 💬 |
308 |
Cas no.: 7758-16-9 |
- |
- |
- |
- |
166 1件: 166 💬 |
309 |
Cas# in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 1件: 254 💬 |
310 |
Casein |
Casein |
- |
- |
- |
097 1件: 97 💬 |
311 |
Casein glycomacropeptide (cgmp) |
Casein |
- |
- |
- |
097 1件: 97 💬 |
312 |
Casimersen |
Casimersen |
1件: D11988 D11988 💬 |
DMD 1件: DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy 4件: Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 1件: 113 💬 |
313 |
Caspofungin |
Caspofungin |
2件: D02501 D02501, D07626 D07626 💬 |
- |
- |
060 1件: 60 💬 |
314 |
Caspofungin acetate |
Acetate |
2件: D02501 D02501, D07626 D07626 💬 |
- |
- |
060 1件: 60 💬 |
315 |
Cat-1004 |
- |
- |
- |
- |
113 1件: 113 💬 |
316 |
Cat-354 |
- |
- |
- |
- |
097 1件: 97 💬 |
317 |
Catapres ampoules |
- |
- |
- |
- |
006 1件: 6 💬 |
318 |
Catapresan |
- |
- |
- |
- |
078 1件: 78 💬 |
319 |
Catapressan |
- |
- |
- |
- |
006 1件: 6 💬 |
320 |
Cathepsin s |
- |
- |
- |
- |
053 1件: 53 💬 |
321 |
Cathepsin s inhibitor |
- |
- |
- |
- |
053 1件: 53 💬 |
322 |
Catridecacog |
Catridecacog |
1件: D10532 D10532 💬 |
- |
- |
097 2件: 97, 288 💬 |
323 |
Caudal epidural injection |
- |
- |
- |
- |
070 1件: 70 💬 |
324 |
Caudal epidural injection with celestone |
- |
- |
- |
- |
070 1件: 70 💬 |
325 |
Caudal epidural injection with depomedrol |
- |
- |
- |
- |
070 1件: 70 💬 |
326 |
Caudal epidural injection with generic celestone |
- |
- |
- |
- |
070 1件: 70 💬 |
327 |
Caveolin-1-scaffolding-protein-derived peptide (lti-03) |
- |
- |
- |
- |
085 1件: 85 💬 |
328 |
Cavosonstat |
Cavosonstat |
1件: D10916 D10916 💬 |
- |
- |
299 1件: 299 💬 |
329 |
Cayston |
- |
- |
- |
- |
299 1件: 299 💬 |
330 |
Cayston 75 mg pulver und lösungsmittel zur herstellung einer lösung für einen vernebler |
- |
- |
- |
- |
299 1件: 299 💬 |
331 |
Cayston aztreonam 75 mg powder and solvent for nebuliser solution |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
332 |
Ceftazidime |
Ceftazidime |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
333 |
Ceftazidime and tobramycin |
Ceftazidime |
4件: D00063 D00063, D00921 D00921, D02542 D02542, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
334 |
Ceftazidime pentahydrate |
Ceftazidime |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
335 |
Ceftazidime/avibactam |
Avibactam |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
336 |
Celebrex 200 mg capsule, hard |
- |
- |
- |
- |
046 1件: 46 💬 |
337 |
Celebrex 200mg capsule |
- |
- |
- |
- |
070 1件: 70 💬 |
338 |
Celecoxib 200mg capsule |
Celecoxib |
1件: D00567 D00567 💬 |
PTGS2 1件: PTGS2 💬 |
Alzheimer disease 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
339 |
Chlorhexidine |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
086 2件: 86, 299 💬 |
340 |
Chlorhexidine gluconate |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
341 |
Chlorhexidine gluconate oral rinse |
Chlorhexidine |
4件: D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 1件: 299 💬 |
342 |
Choline |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 4件: 93, 171, 193, 299 💬 |
343 |
Choline chloride |
Chloride ion |
1件: D07690 D07690 💬 |
- |
- |
299 1件: 299 💬 |
344 |
Choline supplementation |
Choline |
1件: D07690 D07690 💬 |
- |
- |
299 1件: 299 💬 |
345 |
Ck-3773274 - granules in capsule |
- |
- |
- |
- |
058 1件: 58 💬 |
346 |
Clonidine |
Clonidine |
2件: D00281 D00281, D00604 D00604 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 2件: 6 , 78 💬 |
347 |
Clonidine hcl cf 0,150 mg, tabletten |
Clonidine |
2件: D00281 D00281, D00604 D00604 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 1件: 78 💬 |
348 |
Clonidine hydrochloride |
Clonidine |
2件: D00281 D00281, D00604 D00604 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 2件: 6 , 78 💬 |
349 |
Cobamamide |
Cobamamide |
1件: D00042 D00042 💬 |
- |
- |
299 1件: 299 💬 |
350 |
Cofactor supplementation (thiamine, riboflavin, l-carnitine) |
Levocarnitine |
7件: D00050 D00050, D01622 D01622, D01913 D01913, D02030 D02030, D02176 D02176, D04713 D04713, D08580 D08580 💬 |
- |
- |
265 1件: 265 💬 |
351 |
Cohort 1:nilotinib oral capsules (150mg or 300mg) |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 1件: 6 💬 |
352 |
Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 1件: 6 💬 |
353 |
Colchicine sprinkle capsules |
Colchicine |
1件: D00570 D00570 💬 |
TUBB 9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease 10件: Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 1件: 266 💬 |
354 |
Combination product: l-dopa 70mg/carbidopa 7mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
355 |
Comparator: carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
356 |
Comparator: diclofenac |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
357 |
Comparator: diclofenac sodium |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
358 |
Compound thrombosis capsule sig: 1.5g/tid |
- |
- |
- |
- |
090 1件: 90 💬 |
359 |
Continuous infusion ceftazidime |
Ceftazidime |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
360 |
Continuous intrajejunal infusion of levodopa-carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
361 |
Controlled-release levodopa / carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
362 |
Corn oil capsules |
Corn |
- |
- |
- |
046 1件: 46 💬 |
363 |
Cphc (carboxy pyrrolidine hexanoyl pyrrolidone carboxylate) |
- |
- |
- |
- |
028 1件: 28 💬 |
364 |
Creon 10000 capsules |
- |
- |
- |
- |
299 1件: 299 💬 |
365 |
Crestor tablets (calcium rosuvastatin) film-coated tablets |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 1件: 79 💬 |
366 |
Crystalline calcium supplements |
Calcium |
- |
- |
- |
235 1件: 235 💬 |
367 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d) trp-ly di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
368 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d)trp-ly di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
369 |
Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate |
- |
- |
- |
- |
075 1件: 75 💬 |
370 |
Cyclo(diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) |
- |
- |
- |
- |
075 1件: 75 💬 |
371 |
Cyclophosphamide,campath ih and tbi |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
060 1件: 60 💬 |
372 |
Cystagon (cysteamine bitartrate) immediate-release capsules |
Cysteamine |
2件: D03634 D03634, D03635 D03635 💬 |
- |
- |
299 1件: 299 💬 |
373 |
Cysteamine bitartrate delayed-release capsules |
Cysteamine |
2件: D03634 D03634, D03635 D03635 💬 |
- |
- |
019 1件: 19 💬 |
374 |
Cysteamine bitartrate delayed-release capsules (rp103) |
Cysteamine |
2件: D03634 D03634, D03635 D03635 💬 |
- |
- |
019 1件: 19 💬 |
375 |
D9421-c capsule 3 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
376 |
Delayed and extended release mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
377 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
378 |
Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) |
Cannabidiol |
2件: D00306 D00306, D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 1件: 8 💬 |
379 |
Device: air filled balloon catheter |
- |
- |
- |
- |
051 1件: 51 💬 |
380 |
Device: cadd-legacy ambulatory infusion pump |
- |
- |
- |
- |
006 1件: 6 💬 |
381 |
Device: cadd-legacy® 1400 ambulatory infusion pump |
- |
- |
- |
- |
006 1件: 6 💬 |
382 |
Device: capacity of muscular oxygen extraction |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
013 1件: 13 💬 |
383 |
Device: capsule endoscopy |
- |
- |
- |
- |
096 1件: 96 💬 |
384 |
Device: carbon fiber ankle foot orthosis (afo) |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 1件: 6 💬 |
385 |
Device: carbon modular radial head |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
046 1件: 46 💬 |
386 |
Device: carbon modular radial head replacement |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
046 1件: 46 💬 |
387 |
Device: carboxymethylcellulose with ionic silver (aquacel ag) |
Carboxymethylcellulose |
1件: D07622 D07622 💬 |
- |
- |
035 2件: 35, 162 💬 |
388 |
Device: clonidine (catapressan) |
Clonidine |
2件: D00281 D00281, D00604 D00604 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 1件: 6 💬 |
389 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 1件: 13 💬 |
390 |
Device: fractional carbon dioxide laser |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
051 1件: 51 💬 |
391 |
Device: fractionated carbon dioxide (fco2) laser |
Activated charcoal |
2件: D00004 D00004, D03251 D03251 💬 |
- |
- |
050 1件: 50 💬 |
392 |
Device: high flow nasal oxygen cannula |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
299 1件: 299 💬 |
393 |
Device: infusion pump: cadd-legacy® 1400 pump |
- |
- |
- |
- |
006 1件: 6 💬 |
394 |
Device: insertable cardiac monitor |
Methamidophos |
- |
- |
- |
058 1件: 58 💬 |
395 |
Device: interbody cage (peek) |
- |
- |
- |
- |
070 1件: 70 💬 |
396 |
Device: interbody cage (titanium) |
Titanium |
- |
- |
- |
070 1件: 70 💬 |
397 |
Device: relizorb (immobilized lipase) cartridge |
- |
- |
- |
- |
299 1件: 299 💬 |
398 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 1件: 13 💬 |
399 |
Device: smartpill motility system & pillcam patency capsule |
- |
- |
- |
- |
299 1件: 299 💬 |
400 |
Device: solid state catheter |
- |
- |
- |
- |
051 1件: 51 💬 |
401 |
Device: therm-apptm th, thermographic camera |
- |
- |
- |
- |
070 1件: 70 💬 |
402 |
Device: titanium cage |
Titanium |
- |
- |
- |
070 1件: 70 💬 |
403 |
Device: usual care |
- |
- |
- |
- |
086 1件: 86 💬 |
404 |
Dextromethorphan and caffeine |
Caffeine |
5件: D00528 D00528, D00848 D00848, D01453 D01453, D03742 D03742, D03744 D03744 💬 |
ADORA1 17件: ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 |
Alcoholism 37件: Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
078 1件: 78 💬 |
405 |
Dextromethorphan hbr and quinidine sulfate |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 1件: 2 💬 |
406 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
407 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 2件: 2 , 13 💬 |
408 |
Dextromethorphan/quinidine |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 1件: 13 💬 |
409 |
Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg) |
Dextromethorphan |
7件: D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 11件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes 22件: Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
008 1件: 8 💬 |
410 |
Diagnostic test: calprotectin |
- |
- |
- |
- |
097 1件: 97 💬 |
411 |
Diagnostic test: candy glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
299 1件: 299 💬 |
412 |
Diagnostic test: cardiac mri (gadolinium enhanced) |
Gadolinium |
- |
- |
- |
086 1件: 86 💬 |
413 |
Diagnostic test: functional residual capacity |
- |
- |
- |
- |
294 1件: 294 💬 |
414 |
Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 1件: 299 💬 |
415 |
Diagnostic test: simultaneous combined 18f-fdg pet and cardiac mri imaging |
Fludeoxyglucose (18F) |
- |
- |
- |
084 1件: 84 💬 |
416 |
Diazoxide choline |
Choline |
2件: D00294 D00294, D07690 D07690 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 1件: 193 💬 |
417 |
Diazoxide choline controlled-release tablet |
Choline |
2件: D00294 D00294, D07690 D07690 💬 |
ABCC8 2件: ABCC8, KCNJ11 💬 |
ABC transporters 4件: ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 1件: 193 💬 |
418 |
Diclofenac |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 4件: 13, 34, 46, 271 💬 |
419 |
Diclofenac + omeprazole |
Diclofenac |
7件: D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A 4件: ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease 26件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 1件: 46 💬 |
420 |
Diclofenac 50 milligrams |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 1件: 271 💬 |
421 |
Diclofenac sodium |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
034 2件: 34, 46 💬 |
422 |
Diclofenac sodium topical gel |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
423 |
Diclofenac sr |
Diclofenac |
3件: D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 1件: 271 💬 |
424 |
Diltiazem |
Diltiazem |
3件: D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 3件: 51, 58, 86 💬 |
425 |
Diltiazem gel 2% |
Diltiazem |
3件: D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 1件: 51 💬 |
426 |
Diltiazem hydrochloride |
Diltiazem |
3件: D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
427 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) |
Amiodarone |
2件: D00636 D00636, D02910 D02910 💬 |
ADRA1A 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 1件: 28 💬 |
428 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg |
Amiodarone |
2件: D00636 D00636, D02910 D02910 💬 |
ADRA1A 16件: ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 31件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 1件: 28 💬 |
429 |
Doxazosin |
Doxazosin |
2件: D00608 D00608, D07874 D07874 💬 |
ADRA1A 3件: ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway 7件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 2件: 57, 67 💬 |
430 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
431 |
Doxycycline 100 mg capsules |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
089 1件: 89 💬 |
432 |
Doxycycline 100-200mg capsules daily for 6 months |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
167 1件: 167 💬 |
433 |
Doxycycline hyclate |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
023 3件: 23, 96, 227 💬 |
434 |
Doxycycline hyclate ph.eur |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
167 1件: 167 💬 |
435 |
Doxycycline tablets |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
046 1件: 46 💬 |
436 |
Dronabinol capsule 2,5 mg |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 1件: 13 💬 |
437 |
Dronabinol capsule 2.5. mg |
Dronabinol |
1件: D00306 D00306 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
046 2件: 46, 271 💬 |
438 |
Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom |
- |
- |
- |
- |
046 2件: 46, 49 💬 |
439 |
Drug-carbamazepine (tegretol xr) |
Carbamazepine |
1件: D00252 D00252 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
231 1件: 231 💬 |
440 |
Dsg3-caart |
- |
- |
- |
- |
035 1件: 35 💬 |
441 |
Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
442 |
Entacapone and carbidopa |
Carbidopa |
2件: D00558 D00558, D00781 D00781 💬 |
COMT 2件: COMT, DDC 💬 |
Alcoholism 10件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
443 |
Ergocalciferol |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299 💬 |
444 |
Ergocalciferol (vitamin d2) |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
299 1件: 299 💬 |
445 |
Ergocalciferol 1.25 mg tablet |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 1件: 46 💬 |
446 |
Ethylhydrogenfumarat, calciumsalz |
- |
- |
- |
- |
049 1件: 49 💬 |
447 |
Fbs0701 capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
448 |
Fecal microbiota capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
449 |
Fengshigutong capsule |
- |
- |
- |
- |
271 1件: 271 💬 |
450 |
Fengshigutong capsule plus imrecoxib |
Imrecoxib |
- |
- |
- |
271 1件: 271 💬 |
451 |
Ferric carboxy maltose |
Maltose |
1件: D00044 D00044 💬 |
- |
- |
096 1件: 96 💬 |
452 |
Ferric carboxymaltose |
Ferric carboxymaltose |
1件: D08920 D08920 💬 |
- |
- |
086 4件: 86, 96, 97, 299 💬 |
453 |
Filgrastim, alemtuzumab |
Alemtuzumab |
2件: D02802 D02802, D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 1件: 65 💬 |
454 |
Fluocinolone acetonide |
Fluocinolone |
1件: D01825 D01825 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
090 1件: 90 💬 |
455 |
Fosfomycin |
Fosfomycin |
4件: D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 2件: 96, 97 💬 |
456 |
Gabapentin |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 5件: 6 , 13, 19, 70, 298 💬 |
457 |
Gabapentin prescriptions |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 1件: 298 💬 |
458 |
Gaboxadol monohydrate 0.5 mg capsule |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
459 |
Gaboxadol monohydrate 2 mg capsule |
Gaboxadol |
1件: D04282 D04282 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 1件: 201 💬 |
460 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 1件: 13 💬 |
461 |
Gb002 capsules |
- |
- |
- |
- |
086 1件: 86 💬 |
462 |
Gbt440 300 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
463 |
Genetic: amplification by pcr and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene |
- |
- |
- |
- |
265 1件: 265 💬 |
464 |
Glpg0259 oral capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
465 |
Gr181413a/at1001 capsule |
- |
- |
- |
- |
019 1件: 19 💬 |
466 |
Green tea leaf |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
017 1件: 17 💬 |
467 |
Gsk1605786 capsule |
- |
- |
- |
- |
096 1件: 96 💬 |
468 |
Gsk2018682 cd2 capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
469 |
Harmonized supportive care |
- |
- |
- |
- |
038 2件: 38, 39 💬 |
470 |
Hcq/cq and cab combined treatment |
- |
- |
- |
- |
074 1件: 74 💬 |
471 |
Heparin 25mg inhalation powder, hard capsule |
Heparin |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
299 1件: 299 💬 |
472 |
High-caloric fatty diet |
- |
- |
- |
- |
002 1件: 2 💬 |
473 |
High-carbohdyrate breakfast |
- |
- |
- |
- |
265 1件: 265 💬 |
474 |
Hyaluronic acid |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
046 5件: 46, 53, 70, 226, 231 💬 |
475 |
Hyaluronic acid and chondroitin sulfate |
Chondroitin sulfate |
2件: D00080 D00080, D08043 D08043 💬 |
- |
- |
226 1件: 226 💬 |
476 |
Hyaluronic acid inhalation solution |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
231 1件: 231 💬 |
477 |
Hyaluronic acid/chondroitin sulfate |
Chondroitin sulfate |
2件: D00080 D00080, D08043 D08043 💬 |
- |
- |
226 1件: 226 💬 |
478 |
Hydrocortisone modified release capsules |
Hydrocortisone |
1件: D00088 D00088 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
081 1件: 81 💬 |
479 |
Hymecromone |
Hymecromone |
1件: D00170 D00170 💬 |
- |
- |
094 1件: 94 💬 |
480 |
Hyperimmune caprine serum |
- |
- |
- |
- |
051 1件: 51 💬 |
481 |
Hyperimmune caprine serum against hiv lysate |
- |
- |
- |
- |
013 1件: 13 💬 |
482 |
Ibandronate+alfacalcidol+calcium |
Alfacalcidol |
2件: D01518 D01518, D08056 D08056 💬 |
FDPS 2件: FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 8件: Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
049 1件: 49 💬 |
483 |
Ibd98-m delayed-release capsules |
- |
- |
- |
- |
097 1件: 97 💬 |
484 |
Ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 6件: 13, 46, 65, 113, 271, 299 💬 |
485 |
Ibuprofen 200mg |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
486 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
487 |
Idl-2965 oral capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
488 |
Iguratimod (careram) |
Iguratimod |
1件: D01146 D01146 💬 |
NFKB1 1件: NFKB1 💬 |
AGE-RAGE signaling pathway in diabetic complications 72件: AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway |
046 1件: 46 💬 |
489 |
Imatinib mesylate 400mg capsule |
Imatinib |
2件: D01441 D01441, D08066 D08066 💬 |
ABL1 3件: ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia 31件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
089 1件: 89 💬 |
490 |
Immediate release carbidopa/levodopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
491 |
Immediate release carbidopa/levodopa 10/100 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
492 |
Immediate release carbidopa/levodopa 25/100 mg |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
493 |
Immune globulin (human), 10% caprylate/chromatography purified |
- |
- |
- |
- |
011 1件: 11 💬 |
494 |
Immune globulin (human), 10% caprylate/chromatography purified (igiv-c) |
- |
- |
- |
- |
011 1件: 11 💬 |
495 |
Immune globulin intravenous [human], 10% caprylate/chromatography purified |
- |
- |
- |
- |
065 1件: 65 💬 |
496 |
Immune globulin iv (human), 10% caprylate/chromatography purified |
- |
- |
- |
- |
014 1件: 14 💬 |
497 |
Immune globulin iv [human], 10% caprylate/chromatography purified |
- |
- |
- |
- |
013 1件: 13 💬 |
498 |
Immune globulin subcutaneous (human), 20% caprylate/chromatography purified (igsc 20%) |
- |
- |
- |
- |
065 1件: 65 💬 |
499 |
Immune globulin subcutaneous (human), 20%, caprylate/chromatography purified |
- |
- |
- |
- |
065 1件: 65 💬 |
500 |
Imnovid 1 mg hard capsules |
- |
- |
- |
- |
051 1件: 51 💬 |
501 |
Inactive reminder capsules |
- |
- |
- |
- |
019 1件: 19 💬 |
502 |
Inhaled cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
503 |
Inhaled carbon monoxide |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
085 1件: 85 💬 |
504 |
Interferon beta 1a, oral doxycycline |
Doxycycline |
6件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D04554 D04554, D07876 D07876 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
505 |
Interferon beta treatment to add-on atorvastatin treatment |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
506 |
Interferon beta-1b/atorvastatin group |
Atorvastatin |
4件: D00258 D00258, D00746 D00746, D00887 D00887, D07474 D07474 💬 |
HMGCR 3件: HMGCR, IFNAR1, IFNAR2 💬 |
AMPK signaling pathway 22件: AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway |
013 1件: 13 💬 |
507 |
Intermittent, short infusion ceftazidime |
Ceftazidime |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
508 |
Intranasal carbetocin dose 1 |
Carbetocin |
1件: D07229 D07229 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
509 |
Intranasal carbetocin dose 2 |
Carbetocin |
1件: D07229 D07229 💬 |
OXTR 1件: OXTR 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 1件: 193 💬 |
510 |
Intravenous administration of ferric carboxymaltose |
Ferric carboxymaltose |
1件: D08920 D08920 💬 |
- |
- |
086 1件: 86 💬 |
511 |
Iodine |
Iodine |
1件: D00108 D00108 💬 |
- |
- |
046 2件: 46, 88 💬 |
512 |
Ir cd-ld (carbidopa-levodopa) tablets |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
513 |
Irbesartan 150-300mg capsules daily for 6 months |
Irbesartan |
1件: D00523 D00523 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
167 1件: 167 💬 |
514 |
Isoniazid |
Isoniazid |
3件: D00346 D00346, D01501 D01501, D02002 D02002 💬 |
- |
- |
254 1件: 254 💬 |
515 |
Isotopic intravenous [13c]-urea |
Urea |
2件: D00023 D00023, D01749 D01749 💬 |
- |
- |
251 1件: 251 💬 |
516 |
Iv ceftazidime |
Ceftazidime |
2件: D00921 D00921, D07654 D07654 💬 |
- |
- |
299 1件: 299 💬 |
517 |
Ixazomib (ninlaro®) capsules |
Ixazomib |
1件: D10130 D10130 💬 |
PSMB5 1件: PSMB5 💬 |
Alzheimer disease 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 1件: 13 💬 |
518 |
Jkb-122 in capsule or tablet form |
- |
- |
- |
- |
095 1件: 95 💬 |
519 |
Jnj-40346527-aac - capsule - 50 mg |
JNJ-40346527 |
- |
- |
- |
046 1件: 46 💬 |
520 |
Kar5585 capsules |
- |
- |
- |
- |
086 1件: 86 💬 |
521 |
Kremezin®, spherical adsorptive carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
096 2件: 96, 97 💬 |
522 |
Kunxian capsule |
- |
- |
- |
- |
046 2件: 46, 271 💬 |
523 |
L acetyl carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 1件: 13 💬 |
524 |
L-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 6件: 13, 96, 97, 265, 298, 316 💬 |
525 |
Lactobacillus casei dg |
- |
- |
- |
- |
097 1件: 97 💬 |
526 |
Lactobacillus casei dg (enterolactis duo®) |
- |
- |
- |
- |
006 1件: 6 💬 |
527 |
Lactobacillus casei rhamnosus (lcr35) |
- |
- |
- |
- |
296 1件: 296 💬 |
528 |
Lantus 100 units/ml solution for injection in a cartridge |
- |
- |
- |
- |
299 1件: 299 💬 |
529 |
Lantus® 100 units/ml solution for injection in a vial. lantus® 100 units/ml solution for injection in a cartridge. lantus® 100 units/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 1件: 299 💬 |
530 |
Laquinimod capsulas 0.6 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
531 |
Laquinimod capsules 0.3 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
532 |
Laquinimod capsules 0.5 mg |
Laquinimod |
- |
- |
- |
008 2件: 8 , 96 💬 |
533 |
Laquinimod capsules 0.6 mg |
Laquinimod |
- |
- |
- |
013 1件: 13 💬 |
534 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 1件: 51 💬 |
535 |
Lenabasum 5 mg powder in capsule |
- |
- |
- |
- |
051 1件: 51 💬 |
536 |
Leucovorin |
Leucovorin |
3件: D01211 D01211, D07986 D07986, D07987 D07987 💬 |
- |
- |
019 2件: 19, 46 💬 |
537 |
Levemir 100 u/ml solution for injection in a cartridge, levemir 100 u/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 1件: 299 💬 |
538 |
Levocarnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 3件: 3 , 53, 97 💬 |
539 |
Levocarnitine propyl hydrochloride |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
540 |
Levodopa (l-dopa) + standard care |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
541 |
Levodopa 100 mg a cap |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
542 |
Levodopa 125 mg a cap |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
543 |
Levodopa 150 mg a cap |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
544 |
Levodopa 75 mg a cap |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
545 |
Levodopa and carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
546 |
Levodopa and carbidopa sc solution |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
547 |
Levodopa and carbidopa solution for sc administration |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
548 |
Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
549 |
Levodopa carbidopa intestinal gel (lcig) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
550 |
Levodopa, carbidopa, entacapone |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
551 |
Levodopa, carbidopa, odm-104 |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
552 |
Levodopa-carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 2件: 6 , 90 💬 |
553 |
Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
554 |
Levodopa-carbidopa immediate release (lc-ir) tablets |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
555 |
Levodopa-carbidopa intestinal gel |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
556 |
Levodopa-carbidopa intestinal gel (lcig) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
557 |
Levodopa-carbidopa multilayer extended release tablet |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
558 |
Levodopa-carbidopa xl tablet (m) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
559 |
Levodopa-carbidopa-entacapone |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
560 |
Levodopa/carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 2件: 6 , 164 💬 |
561 |
Levodopa/carbidopa (4:1) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
201 1件: 201 💬 |
562 |
Levodopa/carbidopa (ld/cd) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
563 |
Levodopa/carbidopa (sinemet) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
564 |
Levodopa/carbidopa 100/25 |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
565 |
Levodopa/carbidopa hydrate |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
566 |
Levodopa/carbidopa solution |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
567 |
Levodopa/carbidopa(200mg/50mg) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
568 |
Levodopa/carbidopa/entacapone |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
569 |
Lisinopril, losartan, and atorvastatin |
Atorvastatin |
7件: D00258 D00258, D00357 D00357, D00362 D00362, D00887 D00887, D07474 D07474, D08131 D08131, D08146 D08146 💬 |
ACE 3件: ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications 22件: AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
570 |
Lithium carbonate |
Carbonate ion |
1件: D00801 D00801 💬 |
- |
- |
002 6件: 2 , 13, 17, 18, 19, 127 💬 |
571 |
Litio carbonato |
- |
- |
- |
- |
002 2件: 2 , 17 💬 |
572 |
Lojuxta 10 mg hard capsules |
- |
- |
- |
- |
079 1件: 79 💬 |
573 |
Lojuxta 20 mg hard capsules |
- |
- |
- |
- |
079 1件: 79 💬 |
574 |
Lojuxta 5 mg hard capsules |
- |
- |
- |
- |
079 1件: 79 💬 |
575 |
Lomitapide 2mg hard capsules |
Lomitapide |
1件: D09637 D09637 💬 |
MTTP 1件: MTTP 💬 |
Fat digestion and absorption 1件: Fat digestion and absorption |
079 1件: 79 💬 |
576 |
Losec capsules 20 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
577 |
Low calorie protein substitute |
- |
- |
- |
- |
240 1件: 240 💬 |
578 |
Low carbohydrate ketogenic diet |
- |
- |
- |
- |
256 1件: 256 💬 |
579 |
Low dose cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
580 |
Low molecular weight heparin calcium injection |
Calcium |
1件: D07510 D07510 💬 |
SERPINC1 1件: SERPINC1 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
224 1件: 224 💬 |
581 |
Lutein (10 or 30 mg/day) capsules |
Lutein |
- |
- |
- |
090 1件: 90 💬 |
582 |
Lx3305 250 mg capsule |
- |
- |
- |
- |
161 1件: 161 💬 |
583 |
Manufacturerd by cambridge therapeutic antibody centre, burroughs wellcome, glaxo wellcome) |
- |
- |
- |
- |
046 1件: 46 💬 |
584 |
Mbx-8025 10 mg capsule |
MBX-8025 |
- |
- |
- |
093 1件: 93 💬 |
585 |
Mbx-8025 2 mg capsule |
MBX-8025 |
- |
- |
- |
093 1件: 93 💬 |
586 |
Mbx-8025 5 mg capsule |
MBX-8025 |
- |
- |
- |
093 1件: 93 💬 |
587 |
Md1003 100 mg capsule |
- |
- |
- |
- |
020 1件: 20 💬 |
588 |
Md1003 100mg capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
589 |
Medical standard of care for itp |
- |
- |
- |
- |
063 1件: 63 💬 |
590 |
Mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
046 3件: 46, 96, 97 💬 |
591 |
Mesalazine (3,600 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
592 |
Mesalazine (asacol®) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
593 |
Mesalazine (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
594 |
Mesalazine - tid 1000 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
595 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
596 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
597 |
Mesalazine 250mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
598 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
2件: D00377 D00377, D02486 D02486 💬 |
- |
- |
097 1件: 97 💬 |
599 |
Mesalazine 4g enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
600 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
601 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
602 |
Mesalazine ec 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
603 |
Mesalazine enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
604 |
Mesalazine liquid enema |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
605 |
Mesalazine slow-release granules |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
606 |
Mesalazine sustained-release tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
607 |
Mesalazine tablet |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
608 |
Mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
609 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
2件: D00088 D00088, D00377 D00377 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
097 1件: 97 💬 |
610 |
Mesalazine, tripterygium glycosides |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
611 |
Methotrexate capsules |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
612 |
Methotrexate, leucovorin and bms-986142 |
BMS-986142 |
5件: D00142 D00142, D01211 D01211, D02115 D02115, D07986 D07986, D07987 D07987 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 1件: 46 💬 |
613 |
Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb |
- |
- |
- |
- |
086 2件: 86, 88 💬 |
614 |
Metopirone 250 mg capsules |
- |
- |
- |
- |
075 1件: 75 💬 |
615 |
Metopirone 250 mg capsules/cormeto |
- |
- |
- |
- |
075 1件: 75 💬 |
616 |
Metoprolol succinate + doxazosin |
Doxazosin |
5件: D00601 D00601, D00608 D00608, D02358 D02358, D05011 D05011, D07874 D07874 💬 |
ADRA1A 4件: ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 |
AMPK signaling pathway 12件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 1件: 57 💬 |
617 |
Metronidazole capsule 50 mg |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 1件: 97 💬 |
618 |
Mild dose cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
619 |
Mirdametinib (pd-0325901) oral capsule or dispersible tablet |
PD-0325901 |
- |
- |
- |
034 1件: 34 💬 |
620 |
Mmx mesalamine/ mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
621 |
Mmx mesalamine/mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
622 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
623 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
624 |
Monoclonal antibody ca2 |
- |
- |
- |
- |
096 1件: 96 💬 |
625 |
Mtc trx0014-001 capsules |
- |
- |
- |
- |
127 1件: 127 💬 |
626 |
Multi-modal pain management [acetaminophen + gabapentin] |
Acetaminophen |
2件: D00217 D00217, D00332 D00332 💬 |
CACNA2D1 7件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 31件: Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway |
070 1件: 70 💬 |
627 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
1件: D00332 D00332 💬 |
CACNA2D1 5件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 9件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 1件: 70 💬 |
628 |
Mupirocin |
Mupirocin |
2件: D01076 D01076, D02195 D02195 💬 |
- |
- |
227 2件: 227, 299 💬 |
629 |
Mupirocin intranasal creme |
Mupirocin |
2件: D01076 D01076, D02195 D02195 💬 |
- |
- |
299 1件: 299 💬 |
630 |
Mussel oil capsules |
- |
- |
- |
- |
046 1件: 46 💬 |
631 |
N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide |
- |
- |
- |
- |
299 1件: 299 💬 |
632 |
N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide |
- |
- |
- |
- |
299 1件: 299 💬 |
633 |
N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
- |
- |
- |
- |
049 1件: 49 💬 |
634 |
N-(trans-3-(5-((r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide |
- |
- |
- |
- |
299 1件: 299 💬 |
635 |
N-acetylcysteine capsule |
Acetylcysteine |
1件: D00221 D00221 💬 |
- |
- |
006 1件: 6 💬 |
636 |
N-carbamylglutamate |
Carglumic acid |
1件: D07130 D07130 💬 |
CPS1 1件: CPS1 💬 |
Alanine, aspartate and glutamate metabolism 6件: Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism |
245 2件: 245, 246 💬 |
637 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium |
- |
- |
- |
- |
096 1件: 96 💬 |
638 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium |
- |
- |
- |
- |
096 1件: 96 💬 |
639 |
Nacom levodopa+cardidopa |
Levodopa |
1件: D00059 D00059 💬 |
DRD1 5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 11件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 1件: 6 💬 |
640 |
Nasal aztreonam |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
641 |
Nd0612 (levodopa/carbidopa solution) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
642 |
Neoral soft gelatin capsules |
Gelatin |
2件: D00115 D00115, D06892 D06892 💬 |
- |
- |
097 2件: 97, 269 💬 |
643 |
Neurontin 300 mg hard capsule |
- |
- |
- |
- |
013 1件: 13 💬 |
644 |
Nicardipine |
Nicardipine |
2件: D00617 D00617, D08270 D08270 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
070 2件: 70, 86 💬 |
645 |
Nilotinib 150mg oral capsule [tasigna] |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 1件: 6 💬 |
646 |
Nilotinib 300mg oral capsule [tasigna] |
Nilotinib |
1件: D08953 D08953 💬 |
ABL1 4件: ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia 32件: Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 1件: 6 💬 |
647 |
Nnc0195-0092 dp 6.7 mg ml 3 ml cartridge |
- |
- |
- |
- |
078 1件: 78 💬 |
648 |
Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen. |
- |
- |
- |
- |
299 1件: 299 💬 |
649 |
Odm-101 105mg carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
650 |
Odm-101 65mg carbidopa |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
651 |
Odm-109 capsule 1 mg |
- |
- |
- |
- |
002 1件: 2 💬 |
652 |
Ofev 100 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
653 |
Ofev 150 mg capsule |
- |
- |
- |
- |
085 1件: 85 💬 |
654 |
Omaveloxolone capsules, 10 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
655 |
Omaveloxolone capsules, 150 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
656 |
Omaveloxolone capsules, 160 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
657 |
Omaveloxolone capsules, 2.5 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
658 |
Omaveloxolone capsules, 20 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
659 |
Omaveloxolone capsules, 300 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
660 |
Omaveloxolone capsules, 40 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
661 |
Omaveloxolone capsules, 5 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
662 |
Omaveloxolone capsules, 80 mg |
Omaveloxolone |
1件: D10964 D10964 💬 |
NFE2L2 1件: NFE2L2 💬 |
Fluid shear stress and atherosclerosis 5件: Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 1件: 18 💬 |
663 |
Omeprazole 40mg capsule |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
299 1件: 299 💬 |
664 |
Oral aztreonam |
Aztreonam |
2件: D00240 D00240, D06558 D06558 💬 |
- |
- |
299 1件: 299 💬 |
665 |
Oral levodopa and carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
666 |
Oral levodopa/carbidopa |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
667 |
Oral scio-469 capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
668 |
Other: caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
669 |
Other: calcium stable isotope |
Calcium |
- |
- |
- |
186 1件: 186 💬 |
670 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
2件: D03251 D03251, D09706 D09706 💬 |
- |
- |
298 1件: 298 💬 |
671 |
Other: carboxy methyl cellulose |
Methylcellulose |
2件: D00093 D00093, D04996 D04996 💬 |
- |
- |
053 1件: 53 💬 |
672 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 1件: 13 💬 |
673 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 1件: 13 💬 |
674 |
Other: challenge agent: capsaicin |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
019 1件: 19 💬 |
675 |
Other: data capture |
Bifenthrin |
- |
- |
- |
006 1件: 6 💬 |
676 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 2件: 13, 46 💬 |
677 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 1件: 97 💬 |
678 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
679 |
Other: exercise capacity |
- |
- |
- |
- |
299 1件: 299 💬 |
680 |
Other: green tea (camellia sinensis) |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
096 1件: 96 💬 |
681 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
6件: D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 1件: 113 💬 |
682 |
Other: intensive supportive care |
- |
- |
- |
- |
066 1件: 66 💬 |
683 |
Other: liquid meal test (carbohydrate-rich) |
- |
- |
- |
- |
299 1件: 299 💬 |
684 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 1件: 98 💬 |
685 |
Other: mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
686 |
Other: no doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
299 1件: 299 💬 |
687 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 1件: 85 💬 |
688 |
Other: optimized supportive care |
- |
- |
- |
- |
066 1件: 66 💬 |
689 |
Other: palliative care |
- |
- |
- |
- |
019 5件: 19, 65, 120, 160, 326 💬 |
690 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
3件: D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 1件: 235 💬 |
691 |
Other: real-time data capture app |
Bifenthrin |
- |
- |
- |
046 1件: 46 💬 |
692 |
Other: serum calcium concentrations results |
Calcium |
- |
- |
- |
235 1件: 235 💬 |
693 |
Other: standard care |
- |
- |
- |
- |
227 1件: 227 💬 |
694 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
695 |
Other: standard of care (soc) |
- |
- |
- |
- |
062 1件: 62 💬 |
696 |
Other: standard of care sildenafil |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 2件: 90, 301 💬 |
697 |
Other: standard-of-care |
- |
- |
- |
- |
086 1件: 86 💬 |
698 |
Other: usual care |
- |
- |
- |
- |
046 1件: 46 💬 |
699 |
Other: usual care arm exercise |
- |
- |
- |
- |
006 1件: 6 💬 |
700 |
Overencapsulated mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
701 |
Pancrelipase delayed release capsule |
Pancrelipase |
1件: D05349 D05349 💬 |
- |
- |
298 2件: 298, 299 💬 |
702 |
Pasireotide with or without cabergoline |
Cabergoline |
2件: D00987 D00987, D10147 D10147 💬 |
DRD2 6件: DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Alcoholism 14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 1件: 75 💬 |
703 |
Patient current care |
- |
- |
- |
- |
046 1件: 46 💬 |
704 |
Pemine - 150 mg capsule rigide 50 capsule |
- |
- |
- |
- |
171 1件: 171 💬 |
705 |
Physician standard-of-care |
- |
- |
- |
- |
096 1件: 96 💬 |
706 |
Pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 3件: 6 , 53, 299 💬 |
707 |
Pilocarpine hydrochloride |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 1件: 53 💬 |
708 |
Pilocarpine nitrate 5% |
Nitrate |
4件: D00525 D00525, D02200 D02200, D02313 D02313, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 1件: 299 💬 |
709 |
Piperazine |
Piperazine |
6件: D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 1件: 58 💬 |
710 |
Pitavastatin |
Pitavastatin |
1件: D01862 D01862 💬 |
- |
- |
049 1件: 49 💬 |
711 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 1件: 46 💬 |
712 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
2件: D01772 D01772, D06078 D06078 💬 |
PTH1R 1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
713 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 1件: 6 💬 |
714 |
Prednisone capsules |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
041 1件: 41 💬 |
715 |
Pregabalin |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 5件: 13, 36, 46, 70, 298 💬 |
716 |
Pregabalin 75mg |
Pregabalin |
1件: D02716 D02716 💬 |
CACNA2D1 4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes 7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 1件: 70 💬 |
717 |
Probiotic capsule |
- |
- |
- |
- |
006 1件: 6 💬 |
718 |
Probiotic capsules containing lactobacillus rhamnosus gr-1 and l. reuteri rc-14 |
- |
- |
- |
- |
046 1件: 46 💬 |
719 |
Probiotic formula capsule |
- |
- |
- |
- |
097 1件: 97 💬 |
720 |
Probiotic product - cap |
- |
- |
- |
- |
053 1件: 53 💬 |
721 |
Procedure: apheresis catheter placement |
- |
- |
- |
- |
096 1件: 96 💬 |
722 |
Procedure: arginine and clonidine stimulation testing |
Arginine |
3件: D00281 D00281, D00604 D00604, D02982 D02982 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 1件: 78 💬 |
723 |
Procedure: cardiac monitoring |
- |
- |
- |
- |
006 1件: 6 💬 |
724 |
Procedure: carotid ultrasound |
- |
- |
- |
- |
078 1件: 78 💬 |
725 |
Procedure: indirect calorimetry |
- |
- |
- |
- |
299 1件: 299 💬 |
726 |
Procedure: intravenous catheter |
- |
- |
- |
- |
231 1件: 231 💬 |
727 |
Procedure: pilocarpine |
Pilocarpine |
3件: D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 2件: CHRM2, CHRM3 💬 |
Alzheimer disease 13件: Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 1件: 53 💬 |
728 |
Procedure: rf catheter ablation |
- |
- |
- |
- |
058 1件: 58 💬 |
729 |
Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects. |
Bifenthrin |
- |
- |
- |
046 1件: 46 💬 |
730 |
Prograft capsules |
- |
- |
- |
- |
299 1件: 299 💬 |
731 |
Propionyl l-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
732 |
Propionyl l-carnitine hydrochloride |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
733 |
Propionyl-l-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 1件: 97 💬 |
734 |
Protein-carbohydrate supplementation |
- |
- |
- |
- |
113 1件: 113 💬 |
735 |
Prototype capsule gdc-0134 |
- |
- |
- |
- |
002 1件: 2 💬 |
736 |
Quinidine |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 3件: 2 , 8 , 13 💬 |
737 |
Quinidine sulfate |
Quinidine |
4件: D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 1件: 13 💬 |
738 |
Qutenza (8% capsaicin) |
Capsaicin |
1件: D00250 D00250 💬 |
TRPV1 1件: TRPV1 💬 |
Inflammatory mediator regulation of TRP channels 2件: Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
086 1件: 86 💬 |
739 |
Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3) |
Ammonia |
1件: D02916 D02916 💬 |
- |
- |
088 1件: 88 💬 |
740 |
Radiation: computed tomography lung subtraction iodine mapping |
Iodine |
1件: D00108 D00108 💬 |
- |
- |
088 1件: 88 💬 |
741 |
Rapamycin-calcitriol combination |
Calcitriol |
2件: D00129 D00129, D00753 D00753 💬 |
MTOR 2件: MTOR, VDR 💬 |
AMPK signaling pathway 54件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway |
158 1件: 158 💬 |
742 |
Rasagiline 1 mg capsule |
Rasagiline |
3件: D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB 1件: MAOB 💬 |
Alcoholism 14件: Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
743 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
744 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
4件: D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 1件: 13 💬 |
745 |
Rebif new formulation 44mcg multidose cartridge |
- |
- |
- |
- |
013 1件: 13 💬 |
746 |
Reference capsule gdc-0134 |
- |
- |
- |
- |
002 1件: 2 💬 |
747 |
Reminder capsules |
- |
- |
- |
- |
019 1件: 19 💬 |
748 |
Repatha 420 mg solution for injection in cartridge |
- |
- |
- |
- |
079 1件: 79 💬 |
749 |
Retrospective case only |
- |
- |
- |
- |
172 1件: 172 💬 |
750 |
Rhudex 100 mg (127 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
751 |
Rhudex 25 mg (31.75 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
752 |
Rhudex 50 mg (63.5 mg rhudex choline salt) granules |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
753 |
Rhudex choline salt |
Choline |
1件: D07690 D07690 💬 |
- |
- |
093 1件: 93 💬 |
754 |
Rigosertib oral capsules / rigosertib intravenous |
Rigosertib |
1件: D10154 D10154 💬 |
PLK1 1件: PLK1 💬 |
Cell cycle 4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
036 1件: 36 💬 |
755 |
Ritalin la 20mg capsules |
- |
- |
- |
- |
013 1件: 13 💬 |
756 |
Ritalin la 30mg capsules |
- |
- |
- |
- |
013 1件: 13 💬 |
757 |
Ritalin la 40mg capsules |
- |
- |
- |
- |
013 1件: 13 💬 |
758 |
Rituxan (us, canada, japan), mabthera (rest of the world) |
- |
- |
- |
- |
046 1件: 46 💬 |
759 |
Rituxan (us, canada, japan), mabthera (rest of world) |
- |
- |
- |
- |
053 1件: 53 💬 |
760 |
Rivastigmine capsule |
Rivastigmine |
2件: D02558 D02558, D03822 D03822 💬 |
ACHE 1件: ACHE 💬 |
Cholinergic synapse 2件: Cholinergic synapse, Glycerophospholipid metabolism |
006 1件: 6 💬 |
761 |
Rob 803 (capsules 12.5 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
762 |
Rob 803 (capsules 15 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
763 |
Rob 803 (capsules 25 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
764 |
Rob 803 (capsules 6.25 mg) |
- |
- |
- |
- |
046 1件: 46 💬 |
765 |
Rob 803 12.5mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
766 |
Rob 803 15mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
767 |
Rob 803 25mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
768 |
Rob 803 6.25mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
769 |
Rob 803 6.5mg capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
770 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
771 |
Rosuvastatin 10 mg |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
096 1件: 96 💬 |
772 |
Rosuvastatin 20mg |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 1件: 79 💬 |
773 |
Rosuvastatin calcium |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 4件: 49, 79, 97, 299 💬 |
774 |
Rosuvastatin calcium 40mg |
Calcium |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
056 1件: 56 💬 |
775 |
Rwj-445380 capsule 100 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
776 |
Rwj-445380 capsules 150 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
777 |
Rwj-445380 capsules 50 mg |
- |
- |
- |
- |
046 1件: 46 💬 |
778 |
S-adenosyl-methionine (same) capsules |
Ademetionine |
3件: D00019 D00019, D04983 D04983, D07128 D07128 💬 |
- |
- |
093 1件: 93 💬 |
779 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 1件: 6 💬 |
780 |
Seasonal influenza vaccine available for the 2012-2013 vaccine campaign |
- |
- |
- |
- |
084 1件: 84 💬 |
781 |
Seladelpar 10 mg capsule |
- |
- |
- |
- |
093 1件: 93 💬 |
782 |
Seladelpar 5 mg capsule |
- |
- |
- |
- |
093 1件: 93 💬 |
783 |
Sevelamer |
Sevelamer |
3件: D01983 D01983, D06642 D06642, D08512 D08512 💬 |
- |
- |
235 1件: 235 💬 |
784 |
Sildenafil 40mg oral capsule |
Sildenafil |
2件: D02229 D02229, D08514 D08514 💬 |
PDE5A 1件: PDE5A 💬 |
Metabolic pathways 3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
299 1件: 299 💬 |
785 |
Sinemet (carbidopa/levodopa) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
786 |
Sinemet (levodopa/carbidopa) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
787 |
Sinemet plus (levodopa/carbidopa) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
788 |
Sinemet® controlled release (carbidopa/levodopa) |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
789 |
Site specific standard of care comparison |
- |
- |
- |
- |
038 2件: 38, 39 💬 |
790 |
Ski-o-703 capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
791 |
Smoked cannabis |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
792 |
Smoking of cannabis |
Medical Cannabis |
- |
- |
- |
096 2件: 96, 97 💬 |
793 |
Sodium (r)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2h-pyran-4-yl)ethoxy)quinoline-4-ca |
- |
- |
- |
- |
299 1件: 299 💬 |
794 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 3件: 13, 14, 53 💬 |
795 |
Soluble ve cadherin |
- |
- |
- |
- |
051 1件: 51 💬 |
796 |
Spd476 (mesalazine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
797 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
097 1件: 97 💬 |
798 |
Spi-1005 ebselen 200mg capsule x1 |
Ebselen |
- |
- |
- |
299 1件: 299 💬 |
799 |
Spi-1005 ebselen 200mg capsule x2 |
Ebselen |
- |
- |
- |
299 1件: 299 💬 |
800 |
Spi-1005 ebselen 200mg capsule x3 |
Ebselen |
- |
- |
- |
299 1件: 299 💬 |
801 |
Spironolactone |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
058 7件: 58, 67, 86, 113, 210, 218, 225 💬 |
802 |
Spironolactone (drug) |
Spironolactone |
1件: D00443 D00443 💬 |
NR3C2 1件: NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 1件: Aldosterone-regulated sodium reabsorption |
210 1件: 210 💬 |
803 |
Spironolactone and conivaptan |
Conivaptan |
3件: D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A 3件: AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption 6件: Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 1件: 86 💬 |
804 |
Spironolactone captopril carvedilol |
Captopril |
4件: D00251 D00251, D00255 D00255, D00443 D00443, D03415 D03415 💬 |
ACE 7件: ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 |
AMPK signaling pathway 18件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 1件: 86 💬 |
805 |
Ssp-004184 100 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
806 |
Ssp-004184 250 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
807 |
Ssp-004184 375 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
808 |
Ssp-004184 50 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
809 |
Ssp-004184 500 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
810 |
Ssp-004184aq 100 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
811 |
Ssp-004184aq 200 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
812 |
Ssp-004184aq 250 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
813 |
Ssp-004184aq 375 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
814 |
Ssp-004184aq 50 mg capsule |
- |
- |
- |
- |
284 1件: 284 💬 |
815 |
Stalevo (levodopa/ carbidopa/ entacapone) |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
816 |
Stalevo (levodopa/carbidopa/entacapona) |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
817 |
Stalevo (levodopa/carbidopa/entacapone) |
Carbidopa |
3件: D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT 7件: COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
818 |
Standard care |
- |
- |
- |
- |
081 2件: 81, 299 💬 |
819 |
Standard care hyaluronic acid eye drops |
Hyaluronic acid |
1件: D08043 D08043 💬 |
- |
- |
053 1件: 53 💬 |
820 |
Standard of care |
- |
- |
- |
- |
006 12件: 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
821 |
Standard of care for haemophilia a |
- |
- |
- |
- |
288 1件: 288 💬 |
822 |
Standard of care fviii replacement therapy |
- |
- |
- |
- |
288 1件: 288 💬 |
823 |
Standard of care iv antibiotic(s) |
- |
- |
- |
- |
299 1件: 299 💬 |
824 |
Standard of care medications |
- |
- |
- |
- |
171 1件: 171 💬 |
825 |
Standard of care therapy |
- |
- |
- |
- |
028 1件: 28 💬 |
826 |
Standard of care treatment |
- |
- |
- |
- |
245 2件: 245, 246 💬 |
827 |
Standard step-up care |
- |
- |
- |
- |
096 1件: 96 💬 |
828 |
Standardized cannabis extract |
Medical Cannabis |
- |
- |
- |
013 1件: 13 💬 |
829 |
Standrd of care treatment |
- |
- |
- |
- |
064 1件: 64 💬 |
830 |
Sucralfate |
Sucralfate |
1件: D00446 D00446 💬 |
- |
- |
098 1件: 98 💬 |
831 |
Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin) |
Aldosterone |
3件: D00150 D00150, D02014 D02014, D10528 D10528 💬 |
AGTR1 3件: AGTR1, AGTR2, NR3C2 💬 |
AGE-RAGE signaling pathway in diabetic complications 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 1件: 222 💬 |
832 |
Tacrolimus capsule |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 1件: 11 💬 |
833 |
Tacrolimus capsule (low-dose) |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 1件: 227 💬 |
834 |
Tacrolimus capsules |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 2件: 222, 299 💬 |
835 |
Tacrolimus prolonged-release hard capsules |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 1件: 299 💬 |
836 |
Tafamidis meglumine 20 mg soft gelatin capsules |
Gelatin |
4件: D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR 1件: TTR 💬 |
Thyroid hormone synthesis 1件: Thyroid hormone synthesis |
028 1件: 28 💬 |
837 |
Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) |
Gelatin |
4件: D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR 1件: TTR 💬 |
Thyroid hormone synthesis 1件: Thyroid hormone synthesis |
028 1件: 28 💬 |
838 |
Tafamidis meglumine 20mg soft gelatin capsule (commerical image) |
Gelatin |
4件: D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR 1件: TTR 💬 |
Thyroid hormone synthesis 1件: Thyroid hormone synthesis |
028 1件: 28 💬 |
839 |
Tauroursodeoxycholic acid capsules |
Tauroursodeoxycholic acid |
1件: D11836 D11836 💬 |
- |
- |
093 1件: 93 💬 |
840 |
Teriflunomide capsule |
Teriflunomide |
1件: D10172 D10172 💬 |
DHODH 1件: DHODH 💬 |
Biosynthesis of cofactors 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 1件: 13 💬 |
841 |
Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker |
Polyethylene glycol |
2件: D03370 D03370, D06078 D06078 💬 |
PTH1R 1件: PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption 3件: Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 1件: 235 💬 |
842 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
843 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 1件: 86 💬 |
844 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 1件: 86 💬 |
845 |
Tizanidine hydrochloride capsule |
Tizanidine |
2件: D00776 D00776, D08611 D08611 💬 |
ADRA2A 3件: ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 1件: 13 💬 |
846 |
Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore |
- |
- |
- |
- |
299 1件: 299 💬 |
847 |
Topical calcipotriene 0.005% ointment |
Calcipotriol |
1件: D01125 D01125 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 1件: 51 💬 |
848 |
Total glucosides paeony capsules |
- |
- |
- |
- |
271 1件: 271 💬 |
849 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
3件: D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 6件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes 12件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 1件: 70 💬 |
850 |
Transplant conditioning with mobilization and alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
065 1件: 65 💬 |
851 |
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan |
Alemtuzumab |
5件: D00369 D00369, D00583 D00583, D01907 D01907, D02802 D02802, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 2件: 65, 164 💬 |
852 |
Treatment with systemic therapy (doxycycline) |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
162 1件: 162 💬 |
853 |
Trientine dihydrochloride 300mg capsules |
Triethylenetetramine |
- |
- |
- |
171 1件: 171 💬 |
854 |
Trimethaphan |
Trimethaphan |
1件: D00612 D00612 💬 |
CHRNA10 1件: CHRNA10 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
017 1件: 17 💬 |
855 |
Ultra-high-caloric carbohydrate-rich diet |
- |
- |
- |
- |
002 1件: 2 💬 |
856 |
Ultra-high-caloric fatty diet |
- |
- |
- |
- |
002 1件: 2 💬 |
857 |
Untreated to atorvastatin treatment |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 1件: 13 💬 |
858 |
Urea |
Urea |
2件: D00023 D00023, D01749 D01749 💬 |
- |
- |
072 2件: 72, 251 💬 |
859 |
Ursodeoxycholic acid 300mg capsule |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
093 1件: 93 💬 |
860 |
Ursodeoxycholic acid capsules |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
093 1件: 93 💬 |
861 |
Ursofalk® capsules |
- |
- |
- |
- |
093 1件: 93 💬 |
862 |
Usual current care |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
863 |
Valproate, levocarnitine |
Levocarnitine |
4件: D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
864 |
Valproic acid and levocarnitine |
Levocarnitine |
4件: D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT 7件: ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism 17件: Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 1件: 3 💬 |
865 |
Verapamil |
Verapamil |
2件: D00619 D00619, D02356 D02356 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 3件: 96, 140, 167 💬 |
866 |
Verapamil sr |
Verapamil |
2件: D00619 D00619, D02356 D02356 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 1件: 167 💬 |
867 |
Vibrox 100mg capsules |
- |
- |
- |
- |
167 1件: 167 💬 |
868 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 4件: 13, 94, 96, 97 💬 |
869 |
Vidofludimus calcium dihydrate |
Calcium |
- |
- |
- |
097 1件: 97 💬 |
870 |
Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1 |
Choline |
1件: D07690 D07690 💬 |
- |
- |
299 1件: 299 💬 |
871 |
Vyndaqel 20mg soft capsule |
- |
- |
- |
- |
028 1件: 28 💬 |
872 |
Wd-1603 carbidopa and levodopa extended-release tablets |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
873 |
Wd-1603 carbidopa/levodopa extended-release tablets |
Carbidopa |
2件: D00059 D00059, D00558 D00558 💬 |
DDC 6件: DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism 16件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 1件: 6 💬 |
874 |
Xinfeng capsule |
- |
- |
- |
- |
046 1件: 46 💬 |
875 |
Xp21279 and carbidopa (experimental) |
Carbidopa |
1件: D00558 D00558 💬 |
DDC 1件: DDC 💬 |
Alcoholism 9件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 1件: 6 💬 |
876 |
Zonisamide capsules |
Zonisamide |
1件: D00538 D00538 💬 |
CACNA1G 8件: CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 11件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus |
006 1件: 6 💬 |